Cordyceps as potential therapeutic agents for atherosclerosis

Area of Science:

• Pharmacology
• Traditional Chinese Medicine
• Cardiovascular Research

Background:

• Atherosclerosis is a major global health concern, driving the search for novel therapeutic strategies.
• Traditional Chinese medicines, like Cordyceps, are increasingly investigated for their potential in managing complex diseases.
• Existing research highlights Cordyceps' diverse pharmacological activities relevant to atherosclerosis.

Purpose of the Study:

• To review the chemical composition and pharmacological actions of Cordyceps and Ophiocordyceps spp. mycelium.
• To elucidate the mechanisms underlying the anti-atherosclerotic effects of Cordyceps.
• To clarify the nomenclature issues surrounding Cordyceps and Ophiocordyceps sinensis in research.

Main Methods:

• Literature review of studies on Cordyceps and atherosclerosis.
• Analysis of pharmacological actions including anti-inflammatory, antioxidant, cholesterol-lowering, and anti-platelet effects.
• Examination of effects on apoptosis and autophagy in vascular endothelial cells.

Main Results:

• Cordyceps exhibits significant anti-inflammatory and antioxidant properties beneficial for atherosclerosis.
• It effectively lowers cholesterol levels and inhibits platelet aggregation.
• Cordyceps modulates apoptosis and autophagy, crucial processes in vascular health.

Conclusions:

• Cordyceps and Ophiocordyceps spp. mycelium possess significant anti-atherosclerotic potential.
• Understanding its mechanisms can guide the development of new pharmaceutical agents.
• Clarifying terminology is essential for advancing research in this field.